BIOPRO, INC. FDA Inspection Record

FEI 1832656 · Inspections, Form 483s, warning letters and import refusals

BIOPRO, INC. is an FDA-registered facility (FEI 1832656) located in PORT HURON, MI, US. RegDataLab tracks 5 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Oct 7, 2015: No Action Indicated (NAI)
Inspections on record
5 (3 VAI, 2 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
3, latest Sep 9, 2025

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Oct 7, 2015No Action Indicated (NAI)No citations listed
Nov 25, 2014No Action Indicated (NAI)Design output - Lack of or inadequate procedures (21 CFR 820.30(d))
Lack of or inadequate In-process acceptance procedures (21 CFR 820.80(c))
Lack of or inadequate procedures (21 CFR 820.100(a))
Sampling plans (21 CFR 820.250(b))
and 3 more
Feb 3, 2012Voluntary Action Indicated (VAI)Lack of or inadequate complaint procedures (21 CFR 820.198(a))
Software validation for automated processes (21 CFR 820.70(i))
Lack of or inadequate final acceptance procedures (21 CFR 820.80(d))
Calibration, Inspection, etc. Procedures Lack of or Inadequ (21 CFR 820.72(a))
and 3 more
Oct 18, 2010Voluntary Action Indicated (VAI)Acceptable supplier records, inadequate records (21 CFR 820.50(a)(3))
Approval, inadequate purchasing data (21 CFR 820.50(b))
DHR documentation of label release {see also 820.184} (21 CFR 820.120(b))
DMR - not or inadequately maintained (21 CFR 820.181)
Feb 4, 2009Voluntary Action Indicated (VAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Sep 9, 2025Class IIZ-0148-2026BioPro Femoral Head (Metal 22, 28, 32, 36, 40) cobalt chromium and ceramic heads Part… and 5 more products
Potential packaging issue that could compromise the sterile barrier. Defect may result in loss of sterility of the device, presenting…
Feb 1, 2022Class IIZ-0682-2022Titanium MPJ (Toe Implant) TOE JOINT TITANIUM NPC SM, Part ID 16813 and 9 more products
There is an incorrect statement regarding MR Compatibility in the BioPro Titanium MPJ implant IFU (IFU BP102303 rev 05) and patient implant…
Jun 25, 2019Class IIZ-2239-2019K-Wire HBS Sterile, Item Number 19688 - Product Usage: Accessories to the BioPro Go-Ez… and 20 more products
Manufacturing flaw in the sterile barrier system

FDA record score

7 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 22, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

6 records behind this number
RecordDatePoints x age weightAdds
Class II recall Z-0148-2026, this FEI as the recalling firmSep 9, 20254 x 14
Class II recall Z-0682-2022, this FEI as the recalling firmFeb 1, 20224 x 0.62.4
Class II recall Z-2239-2019, this FEI as the recalling firmJun 25, 20194 x 0.251
Inspection classified VAIFeb 3, 201210 years or older, so it adds no points0
Inspection classified VAIOct 18, 201010 years or older, so it adds no points0
Inspection classified VAIFeb 4, 200910 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 22, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 22, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 22, 2026Newest record Nov 13, 2026Current
Warning letter textNov 22, 2026Newest record Nov 17, 2026Current
Recalls (Enforcement Report)Nov 22, 2026Newest record Nov 18, 2026Current
Form 483s and inspection documentsNov 18, 2026Newest record Nov 17, 2026Current
Import refusalsNov 22, 2026Newest record Nov 12, 2026Current

Reviewing BIOPRO, INC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check BIOPRO, INC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
BioPro, Inc.
Location
PORT HURON, MI (US)
Source
device

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.